| Structure | Chemical Name | CAS | MF |
|
3-N-FMOC-3-(2-FLUOROPHENYL)PROPIONIC ACID
|
284492-05-3
|
C24H20FNO4
|
|
N-FMOC-3-AMINO-3-M-TOLYL-PROPIONIC ACID
|
284492-06-4
|
C25H23NO4
|
|
3-N-FMOC-3-(3-FLUOROPHENYL)PROPIONIC ACID
|
284492-07-5
|
C24H20FNO4
|
|
3-N-FMOC-3-(4-METHYLPHENYL)PROPIONIC ACID
|
284492-08-6
|
C25H23NO4
|
|
3-(3,4-DICHLORO-PHENYL)-3-(9 H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-PROPIONIC ACID
|
284492-13-3
|
C24H19Cl2NO4
|
|
FMOC-DL-3-(2-CHLOROPHENYL)-3-AMINO-PROPIONIC ACID
|
284492-14-4
|
C24H20ClNO4
|
|
3-(3-CHLORO-PHENYL)-3-(9 H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-PROPIONIC ACID
|
284492-15-5
|
C24H20ClNO4
|
|
3-N-BOC-3-(3-NITROPHENYL)PROPIONIC ACID
|
284492-22-4
|
C14H18N2O6
|
|
3-[(TERT-BUTOXYCARBONYL)AMINO]-3-(3-THIENYL)PROPANOIC ACID
|
284492-23-5
|
C12H17NO4S
|
|
3-TERT-BUTOXYCARBONYLAMINO-3-FURAN-3-YL-PROPIONIC ACID
|
284492-24-6
|
C12H17NO5
|
|
3-TERT-BUTOXYCARBONYLAMINO-3-(3,4-DIMETHOXY-PHENYL)-PROPIONIC ACID
|
284492-37-1
|
C16H23NO6
|
|
3-TERT-BUTOXYCARBONYLAMINO-3-(2,3-DIMETHOXY-PHENYL)-PROPIONIC ACID
|
284492-38-2
|
C16H23NO6
|
|
alpha-D-ribo-Hexopyranoside,methyl2,3-anhydro-4-deoxy-(9CI)
|
284493-19-2
|
C7H12O4
|
|
3-TERT-BUTOXYCARBONYLAMINO-3-(2-METHOXY-PHENYL)-PROPIONIC ACID
|
284493-52-3
|
C15H21NO5
|
|
3-(BOC-AMINO)-3-(3-METHOXYPHENYL)PROPIONIC ACID
|
284493-53-4
|
C15H21NO5
|
|
3-TERT-BUTOXYCARBONYLAMINO-3-O-TOLYL-PROPIONIC ACID
|
284493-54-5
|
C15H21NO4
|
|
3-(2-Bromo-phenyl)-3-tert-butoxycarboxycarbonylamino-propionic acid
|
284493-55-6
|
C14H18BrNO4
|
|
3-N-BOC-3-(2-FLUOROPHENYL)PROPIONIC ACID
|
284493-56-7
|
C14H18FNO4
|
|
3-[(TERT-BUTOXYCARBONYL)AMINO]-3-(3-METHYLPHENYL)PROPANOIC ACID
|
284493-57-8
|
C15H21NO4
|
|
3-(3-BROMO-PHENYL)-3-TERT-BUTOXYCARBONYLAMINO-PROPIONIC ACID
|
284493-58-9
|
C14H18BrNO4
|
|
3-[(TERT-BUTOXYCARBONYL)AMINO]-3-(3-FLUOROPHENYL)PROPANOIC ACID
|
284493-59-0
|
C14H18FNO4
|
|
3-N-BOC-3-(4-METHYLPHENYL)PROPIONIC ACID
|
284493-60-3
|
C15H21NO4
|
|
3-TERT-BUTOXYCARBONYLAMINO-3-(4-ETHYL-PHENYL)-PROPIONIC ACID
|
284493-61-4
|
C16H23NO4
|
|
3-N-Boc-3-(2,3-dichlorophenyl)propionic acid
|
284493-64-7
|
C14H17Cl2NO4
|
|
3-N-Boc-Amino-3-(4-chlorophenyl)propionic acid
|
284493-65-8
|
C14H18ClNO4
|
|
3-BOC-AMINO-3-(2'-CHLOROPHENYL)PROPIONIC ACID
|
284493-66-9
|
C14H18ClNO4
|
|
3-TERT-BUTOXYCARBONYLAMINO-3-(3-CHLORO-PHENYL)-PROPIONIC ACID
|
284493-67-0
|
C14H18ClNO4
|
|
3-TERT-BUTOXYCARBONYLAMINO-3-(3-HYDROXY-PHENYL)-PROPIONIC ACID
|
284493-68-1
|
C14H19NO5
|
|
3-TERT-BUTOXYCARBONYLAMINO-3-(2,3,4-TRIMETHOXY-PHENYL)-PROPIONIC ACID
|
284493-70-5
|
C17H25NO7
|
|
3-[(TERT-BUTOXYCARBONYL)AMINO]-3-(4-FLUOROPHENYL)PROPANOIC ACID
|
284493-72-7
|
C14H18FNO4
|
|
3-(3-BROMOPHENYL)-N,N,N-TRIETHYL-3-OXOPROP-1-EN-1-AMINIUM CHLORIDE
|
284493-93-2
|
C15H21BrClNO
|
|
D-erythro-Pentaric acid, 3,4-dideoxy-4-methyl-, 5,2-lactone, 1-methyl ester
|
284494-70-8
|
C7H10O4
|
|
RARECHEM AL FB 0058
|
284496-06-6
|
C12H9ClN2OS2
|
|
AC-ILE-TYR(PO3H2)-GLY-GLU-PHE-NH2
|
284660-72-6
|
C33H45N6O12P
|
|
2-Methoxycarbonylindole-5-boronicacid
|
284660-86-2
|
C10H10BNO4
|
|
DPC-681
|
284661-68-3
|
C35H48FN5O5S
|
|
Acetamide, N-(2-formyl-1-cyclohepten-1-yl)-
|
284662-82-4
|
C10H15NO2
|
|
2-CHLORO-6-METHYL-3-PHENYLQUINOLINE
|
284664-59-1
|
C16H12ClN
|
|
CREATINE-D3 HYDRATE
|
284664-83-1
|
|
|
3-METHYLHEXANE-D16
|
284664-84-2
|
C7H16
|
|
3-(TRIMETHYLSILYL)-1-PROPANESULFONIC ACI
|
284664-85-3
|
C6H9D6O3SSi.Na
|
|
CREATINE-(METHYL-D3) MONOHYDRATE
|
284664-86-4
|
C4H11N3O3
|
|
DL-LYSINE-3,3,4,4,5,5,6,6-D8 2HCL
|
284664-87-5
|
C6H6D8N2O2.2ClH
|
|
DL-LYSINE-4,4,5,5-D4 2HCL
|
284664-88-6
|
C6H10D4N2O2.2ClH
|
|
DL-PHENYL-D5-ALANINE
|
284664-89-7
|
C9H6D5NO2
|
|
L-LYSINE-4,4,5,5-D4 HCL
|
284664-96-6
|
C6H15ClN2O2
|
|
L-ALANINE-3,3,3-D3-N-FMOC
|
284665-07-2
|
C18H14D3NO4
|
|
GLYCINE-2,2-D2-N-FMOC
|
284665-11-8
|
C17H15NO4
|
|
D-METHIONINE-D3 (S-METHYL-D3)
|
284665-18-5
|
C5H11NO2S
|
|
DL-METHIONINE-D3
|
284665-20-9
|
C5H11NO2S
|
|
1,4-BUTANE-D8-DIAMINE 2HCL
|
284665-22-1
|
C4H13ClN2
|
|
(1S,2S)-(+)-PSEUDOEPHEDRINE-D3 HCL (N-METHYL-D3)
|
284665-25-4
|
C10H16ClNO
|
|
3-[3-AMINO-4-(2-METHOXYETHOXY)PHENYL]PROPANOIC ACID
|
284665-32-3
|
C12H17NO4
|
|
4-(3,5-BIS-TRIFLUOROMETHYLPHENYL)THIAZOL-2-YLAMINE
|
284665-40-3
|
C11H6F6N2S
|
|
3-Methyl-N-(3,4-diMethylphenyl)benzaMide, 97%
|
284668-70-8
|
C16H17NO
|
|
Carbamic acid, 6-heptenyl-, 1,1-dimethylethyl ester (9CI)
|
284670-71-9
|
C12H23NO2
|
|
Sorafenib Impurity 3
|
284670-98-0
|
C27H24N6O5
|
|
1-tert-butyl-3-(naphthalen-2-ylMethyl)-1H-pyrazolo[3,4-d]pyriMidin-4-aMine
|
284672-30-6
|
C20H21N5
|
|
6H-Purin-6-one, 1,7-dihydro-, O-ethyloxime (9CI)
|
284672-31-7
|
C7H9N5O
|
|
20-Deacetyltaxuspine X
|
284672-76-0
|
C39H48O13
|
|
9-Deacetyltaxinine E
|
284672-78-2
|
C35H44O9
|
|
4-(2-METHOXY-ETHYLAMINO)-3-NITRO-BENZOIC ACID
|
284672-80-6
|
C10H12N2O5
|
|
Benzoic acid, 3-amino-4-[(2-methoxyethyl)amino]- (9CI)
|
284672-81-7
|
C10H14N2O3
|
|
Methyl 1-isopropylbenzoiMidazole-5-carboxylate
|
284672-84-0
|
C12H14N2O2
|
|
4-(ISOPROPYLAMINO)-3-NITROBENZOIC ACID
|
284672-95-3
|
C10H12N2O4
|
|
Benzoic acid, 3-amino-4-[(1-methylethyl)amino]- (9CI)
|
284673-06-9
|
C10H14N2O2
|
|
1-Benzyl-1,3-benzodiazole-5-carboxylic acid
|
284673-18-3
|
C15H12N2O2
|
|
2,9-Difluoro-5,12-dimethyl-5,12-dihydroquino2,3-bacridine-7,14-dione
|
284673-30-9
|
C22H14F2N2O2
|
|
5,12-Dimethyl-2,9-bis-trifluoromethyl-5,12-dihydroquino2,3-bacridine-7,14-dione
|
284673-31-0
|
C24H14F6N2O2
|
|
7-IODOACETAMIDOCOUMARIN-4-CARBOXYLIC ACID
|
284679-24-9
|
C12H8INO5
|
|
2,4-DIAMINO-6-(2,6-DIFLUOROPHENYL)-1,3,&
|
284679-95-4
|
C9H7F2N5
|
|
3-Nitro-4-(1-pyrrolidino)benzaldehyde
|
284679-97-6
|
C11H12N2O3
|
|
6-Methyl-2-pyrrolidin-1-ylpyrimidin-4(3H)-one
|
284680-44-0
|
C9H13N3O
|
|
2-(2,4-dichlorophenoxy)-N-(4-sulfamoylphenyl)propanamide
|
284680-59-7
|
C15H14Cl2N2O4S
|
|
5-(4-BROMO-PHENYL)-ISOTHIAZOLE
|
284680-72-4
|
C9H6BrNS
|
|
5-HYDROXYPYRIMIDINE
|
284682-27-5
|
C4H4N2O
|
|
(S)-(-)-Nicotine-d4
|
284685-07-0
|
C10H14N2
|
|
2-AMino Nevirapine
|
284686-15-3
|
C15H15N5O
|
|
2-Nitro Nevirapine
|
284686-16-4
|
C15H13N5O3
|
|
N-Cyclopropyl-4-Methyl-3-nitro-2-pyridinaMine
|
284686-17-5
|
C9H11N3O2
|
|
N2-Cyclopropyl-4-Methyl-2,3-pyridinediaMine
|
284686-18-6
|
C9H13N3
|
|
2-Chloro-N-[2-(cyclopropylaMino)-4-Methyl-3-pyridinyl]-3-pyridinecarboxaMide
|
284686-19-7
|
C15H15ClN4O
|
|
N-[5-BroMo-2-(cyclopropylaMino)-4-Methyl-3-pyridinyl]-2-chloro-3-pyridinecarboxaMide
|
284686-20-0
|
C15H14BrClN4O
|
|
3-BroMo Nevirapine
|
284686-21-1
|
C15H13BrN4O
|
|
3-Ethenyl Nevirapine
|
284686-22-2
|
C17H16N4O
|
|
6-BroMo-2-(phenylaMino)quinazolin-4(3H)-one
|
284686-84-6
|
C14H10BrN3O
|
|
2-(BenzylaMino)-6-broMoquinazolin-4(3H)-one
|
284686-86-8
|
C15H12BrN3O
|
|
8-(BROMOMETHYL)-2,3-DIMETHYL-7,8-DIHYDRO-4H-[1,3]THIAZOLO[3,2-A]THIENO[3,2-E]PYRIMIDIN-4-ONE
|
284687-86-1
|
C11H11BrN2OS2
|
|
HUMAN LEUKOCYTE IFN
|
284690-33-1
|
|
|
TERT-BUTYL [(6-CHLOROPYRIDIN-3-YL)METHYL]CARBAMATE
|
285119-72-4
|
C11H15ClN2O2
|
|
Oxazolidine, 2-(1-methylethyl)-4-(2-methylpropyl)-, (4S)- (9CI)
|
285124-27-8
|
C10H21NO
|
|
Carbamic acid, [(1R)-1-(2-hydroxyethyl)-2-methylpropyl]-, 1,1-dimethylethyl
|
285124-33-6
|
C11H23NO3
|
|
3-ISOBUTYLAMINO-PROPAN-1-OL
|
285124-45-0
|
C7H17NO
|
|
4-Cyano-2-(trifluoromethyl)phenylisothiocyanate
|
285125-02-2
|
C9H3F3N2S
|
|
Pyridine, 4-isothiocyanato-3-methyl- (9CI)
|
285125-09-9
|
C7H6N2S
|
|
2(1H)-Pyridinethione, 1-[(chlorodimethylsilyl)methyl]-6-methyl-
|
285127-22-2
|
C9H14ClNSSi
|
|
2(1H)-Pyridinethione, 1-[(fluorodimethylsilyl)methyl]-6-methyl-
|
285127-26-6
|
C9H14FNSSi
|
|
ETHYL (S)-2-HYDROXY-2-METHYLBENZENEPROPANOATE
|
285130-47-4
|
C12H16O3
|
|
2,6-DIMETHYLPHENOL-3,4,5-D3,OD
|
285132-85-6
|
C8H10O
|
|
DIETHYL-D10-AMINE HYDROCHLORIDE
|
285132-87-8
|
C4H12ClN
|